Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-11-309615
Filing Date
2011-11-14
Accepted
2011-11-14 10:36:40
Documents
12
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d224616d10q.htm 10-Q 301835
2 FOURTH AMENDEMENT TO AMENDED AND RESTATED 2002 PLAN d224616dex45.htm EX-4.5 3005
3 EXECUTIVE EMPLOYMENT AGREEMENT d224616dex1016.htm EX-10.16 25376
4 CERTIFICATION d224616dex311.htm EX-31.1 9434
5 CERTIFICATION d224616dex312.htm EX-31.2 9405
6 CERTIFICATION d224616dex321.htm EX-32.1 3279
7 CERTIFICATION d224616dex322.htm EX-32.2 3171
  Complete submission text file 0001193125-11-309615.txt   1097425

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT orni-20110930.xml EX-101.INS 58573
9 XBRL TAXONOMY EXTENSION SCHEMA orni-20110930.xsd EX-101.SCH 10713
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE orni-20110930_cal.xml EX-101.CAL 29008
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE orni-20110930_lab.xml EX-101.LAB 97176
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE orni-20110930_pre.xml EX-101.PRE 63708
Mailing Address 12085 RESEARCH DRIVE ALACHUA FL 32615
Business Address 12085 RESEARCH DRIVE ALACHUA FL 32615 3864184018
ORAGENICS INC (Filer) CIK: 0001174940 (see all company filings)

EIN.: 593410522 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32188 | Film No.: 111198839
SIC: 2834 Pharmaceutical Preparations